{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P56915",
      "entity_text" : "GSC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9Y6F9",
      "entity_text" : "WNT6",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "This might be linked to the WNT6 oncogenic activities, such as increased invasion / migration hampering complete tumor resection, increased tumor relapse probability due to its roles in GSC maintenance, and the response to TMZ treatment, which is still the gold-standard chemotherapeutic drug used for GBM patients.",
  "reading_complete" : "2020-08-03T14:50:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:47:48Z",
  "trigger" : "increased",
  "evidence" : [ "WNT6 oncogenic activities, such as increased invasion/migration hampering complete tumor resection, increased tumor relapse probability due to its roles in GSC" ],
  "pmc_id" : "6160775",
  "score" : 0
}